662 related articles for article (PubMed ID: 33724992)
1. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study.
Abdu M; Ali Y; Anteneh S; Yesuf M; Birhanu A; Mohamed S; Hussien A
PLoS One; 2021; 16(3):e0248490. PubMed ID: 33724992
[TBL] [Abstract][Full Text] [Related]
2. Determinant factors for adherence to antiretroviral therapy among adult HIV patients at Dessie Referral Hospital, South Wollo, Northeast Ethiopia: a case-control study.
Abdu M; Walelgn B
AIDS Res Ther; 2021 Jul; 18(1):39. PubMed ID: 34256788
[TBL] [Abstract][Full Text] [Related]
3. Determinants of first-line antiretroviral treatment failure among adult patients on treatment in Mettu Karl Specialized Hospital, South West Ethiopia; a case control study.
Zenu S; Tesema T; Reshad M; Abebe E
PLoS One; 2021; 16(10):e0258930. PubMed ID: 34679085
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
Aemro A; Jember A; Anlay DZ
BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
[TBL] [Abstract][Full Text] [Related]
5. Predictors of virological treatment failure among adult HIV patients on first-line antiretroviral therapy in Woldia and Dessie hospitals, Northeast Ethiopia: a case-control study.
Ahmed M; Merga H; Jarso H
BMC Infect Dis; 2019 Apr; 19(1):305. PubMed ID: 30943903
[TBL] [Abstract][Full Text] [Related]
6. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study.
Kibret KT; Yalew AW; Belaineh BG; Asres MM
PLoS One; 2013; 8(5):e64488. PubMed ID: 23762214
[TBL] [Abstract][Full Text] [Related]
7. Predictors of tuberculosis infection among adults visiting anti-retroviral treatment center at east and west Gojjam, northwest, Ethiopia, 2017.
Belew H; Wubie M; Tizazu G; Bitew A; Birlew T
BMC Infect Dis; 2020 Aug; 20(1):593. PubMed ID: 32787798
[TBL] [Abstract][Full Text] [Related]
8. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
[TBL] [Abstract][Full Text] [Related]
9. Sleep quality and associated factors among adult people living with HIV on follow-up at Dessie Town Governmental Health Facilities Antiretroviral Therapy Clinics, Northeast, Ethiopia, 2020, a multicenter cross-sectional study.
GebreEyesus FA; Degu FS; Yohanes YB; Azagew AW
BMC Psychiatry; 2023 Mar; 23(1):132. PubMed ID: 36864404
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral therapy adherence among patients enrolled after the initiation of the Universal Test and Treat strategy in Dessie town: a cross-sectional study.
Damtie Y; Tadese F
Int J STD AIDS; 2020 Aug; 31(9):886-893. PubMed ID: 32702282
[TBL] [Abstract][Full Text] [Related]
11. Adherence to antiretroviral therapy and associated factors among HIV positive adults attending care and treatment in University of Gondar Referral Hospital, Northwest Ethiopia.
Molla AA; Gelagay AA; Mekonnen HS; Teshome DF
BMC Infect Dis; 2018 Jun; 18(1):266. PubMed ID: 29879913
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral treatment failure and associated factors among HIV patients on first-line antiretroviral treatment in Sekota, northeast Ethiopia.
Nega J; Taye S; Million Y; Rodrigo C; Eshetie S
AIDS Res Ther; 2020 Jul; 17(1):39. PubMed ID: 32650796
[TBL] [Abstract][Full Text] [Related]
13. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
Hailu GG; Wasihun AG
BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
[TBL] [Abstract][Full Text] [Related]
14. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia.
Gedle D; Kumera G; Eshete T; Ketema K; Adugna H; Feyera F
J Health Popul Nutr; 2017 May; 36(1):15. PubMed ID: 28506307
[TBL] [Abstract][Full Text] [Related]
15. Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia.
Weldegebreal T; Ahmed I; Muhiye A; Belete S; Bekele A; Kaba M
BMC Public Health; 2018 Jul; 18(1):820. PubMed ID: 29970047
[TBL] [Abstract][Full Text] [Related]
16. Determinants of virologic failure among adult HIV patients on first line antiretroviral treatment in Oromia, Central Ethiopia: 2022 a case-control study.
Ayana WG; Ayana Hordofa M; Dechasa Yadeta A
AIDS Res Ther; 2024 Jun; 21(1):42. PubMed ID: 38915090
[TBL] [Abstract][Full Text] [Related]
17. Magnitude of first line antiretroviral therapy treatment failure and associated factors among adult patients on ART in South West Shoa, Central Ethiopia.
Mulisa D; Tolossa T; Wakuma B; Etafa W; Yadesa G
PLoS One; 2020; 15(11):e0241768. PubMed ID: 33175902
[TBL] [Abstract][Full Text] [Related]
18. Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
Gupta-Wright A; Wood R; Bekker LG; Lawn SD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):261-70. PubMed ID: 23846570
[TBL] [Abstract][Full Text] [Related]
19. Development of tuberculosis in human immunodeficiency virus infected patients receiving antiretroviral therapy.
Martín-Echevarria E; Serrano-Villar S; Sainz T; Moreno A; Casado JL; Dronda F; Elías MJ; Navas E; Zapata MR; Moreno S
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1080-4. PubMed ID: 25189556
[TBL] [Abstract][Full Text] [Related]
20. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
